Publication | Closed Access

Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (Trial 1) and in combination with 5-fluorouracil (Trial 2) in advanced colorectal cancer

OncologyGastrointestinal OncologyPathologyColorectal CancerTrial 1Cancer TreatmentAdvanced Colorectal CancerMedicineRadiation OncologyTrial 2